Xenetic Biosciences(XBIO) - 2025 Q3 - Quarterly Results

Financial Performance - Xenetic Biosciences, Inc. reported financial results for the three months ended September 30, 2025[6]. - The company issued a press release on November 13, 2025, detailing its performance metrics[6]. - Specific financial figures and performance indicators are included in the press release, which is referenced as Exhibit 99.1[9]. - The report does not provide detailed numerical data or specific performance percentages in the available content[6][8]. - The company’s financial statements and additional exhibits are filed with the SEC[9]. Future Outlook - Forward-looking statements indicate expectations for future performance, subject to various risks and uncertainties[8]. - The company is subject to market factors and economic conditions that may impact its operations and results[8]. Product and Market Development - The company has not indicated any new product developments or market expansions in the provided documents[8]. - There is no mention of mergers or acquisitions in the current report[8]. Signatory Information - The report is signed by James Parslow, Interim Chief Executive Officer and Chief Financial Officer[13].